ScholarIQanswers from OpenAlex

Predicting survival in newly diagnosed idiopathic pulmonary fibrosis: a 3-year prospective study

PaperCitations, authors & open-access status

Predicting survival in newly diagnosed idiopathic pulmonary fibrosis: a 3-year prospective study is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Predicting survival in newly diagnosed idiopathic pulmonary fibrosis: a 3-year prospective study have?

ScholarIQcitation count

Predicting survival in newly diagnosed idiopathic pulmonary fibrosis: a 3-year prospective study has 229 citations in the OpenAlex counts ScholarIQ stores.

When was Predicting survival in newly diagnosed idiopathic pulmonary fibrosis: a 3-year prospective study published?

ScholarIQyear

Predicting survival in newly diagnosed idiopathic pulmonary fibrosis: a 3-year prospective study has 2012 year in the ScholarIQ index.

What is the open-access status of Predicting survival in newly diagnosed idiopathic pulmonary fibrosis: a 3-year prospective study?

ScholarIQoa status

Predicting survival in newly diagnosed idiopathic pulmonary fibrosis: a 3-year prospective study has bronze oa status in the ScholarIQ index.

What is the DOI of Predicting survival in newly diagnosed idiopathic pulmonary fibrosis: a 3-year prospective study?

ScholarIQdoi

The DOI for Predicting survival in newly diagnosed idiopathic pulmonary fibrosis: a 3-year prospective study is on the source record.

What is the PMID of Predicting survival in newly diagnosed idiopathic pulmonary fibrosis: a 3-year prospective study?

ScholarIQpmid

The PMID for Predicting survival in newly diagnosed idiopathic pulmonary fibrosis: a 3-year prospective study is on the source record.

What is the OpenAlex record for Predicting survival in newly diagnosed idiopathic pulmonary fibrosis: a 3-year prospective study?

ScholarIQopenalex

The OpenAlex for Predicting survival in newly diagnosed idiopathic pulmonary fibrosis: a 3-year prospective study is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial